Advancing Biopharmaceuticals
and Medical Technologies
in Cardiovascular Medicine

COVID-19 Keeping up trial safety and progress

Services

Accelerate Your Research in Cardiovascular Trials

is a full-service contract research organization (CRO) specialized in cardiovascular research. Our services cover the whole spectrum of development.

References

We Share Your Enthusiasm for Finding Effective Therapies

works with biopharmaceutical and medical technology companies across all phases of development. Our deep expertise in cardiovascular medicine makes us a strong partner for your cardiovascular trials.

About

Together We Find the Right Solution

Accessible and responsive leadership, dedicated staff, and a specialized site network – this is how we help study sponsors develop innovative therapies.

References

Clients & Partners

BLOG

Discover the latest updates on cardiovascular research

Prof. Dr. Thomas Bernd Dschietzig, CEO of Relaxera, and Prof. Dr. Hans-Dirk Düngen, CEO of SCIRENT, at the SCIRENT booth during ESC 2025 in Madrid. The two experts discuss the SOURCE-HF phase 2 clinical trial investigating relaxin-2 in heart failure.
Conferences

SOURCE-HF Phase 2 Study – collaboration announcement between Relaxera and Scirent

A behind-the-scenes look at ESC 2025 in Madrid At this year’s European Society of Cardiology (ESC) Congress in Madrid, the spotlight was not only on cutting-edge research and innovation in cardiovascular medicine. One of the highlights at the SCIRENT booth was a video...
SCIRENT booth at ESC Heart Failure 2025 in Belgrade with people networking, seated discussions, and clinical research banners in the background.
Conferences

ESC Heart Failure 2025 – A Very Special Congress for SCIRENT in Belgrade

The ESC Heart Failure Congress in Belgrade this year was a truly special event for all of us at SCIRENT. Not only because it is one of the most important international gatherings in our field, but also because it was...
SCIRENT invites you to ACC.25 in Chicago, showcasing their expertise in cardiovascular trials and partnerships in biopharma and medtech.
Conferences

SCIRENT is heading to ACC.25 in Chicago!

We’re excited to announce that SCIRENT, a leading Contract Research Organization (CRO) specializing in cardiovascular research, will be attending the American College of Cardiology's Annual Scientific SessionACC.25, taking place from March 29–31, 2025 at McCormick Place, Chicago, IL. With over 300 sessions, groundbreaking research presentations, and unparalleled networking...

Thank you for your application.

We will get in touch shortly.

Thank you. Your data was submitted successfully.

We will get in touch shortly.